Current industrial practices of assessing permeability and P-glycoprotein interaction
Open Access
- 1 March 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 8 (1), E1-E13
- https://doi.org/10.1208/aapsj080101
Abstract
Combination of the in vitro models that are high throughput but less predictive and the in vivo models that are low throughput but more predictive is used effectively to evaluate the intestinal permeability and transport characteristics of a large number of drug candidates during lead selection and lead optimization processes. Parallel artificial membrane permeability assay and Caco-2 cells are the most frequently used in vitro models to assess intestinal permeability. The popularity of these models stems from their potential for high throughput, cost effectiveness, and adequate predictability of absorption potential in humans. However, several caveats associated with these models (eg, poor predictability for transporter-mediated and paracellularly absorbed compounds, significant nonspecific binding to cells/devices leading to poor recovery, variability associated with experimental factors) need to be considered carefully to realize their full potential. P-glycoprotein, among other pharmaceutically relevant transporters, has been well demonstrated to be the major determinant of drug disposition. The review article presents an objective analysis of the permeability and transporter models currently being used in the pharmaceutical industry and could help guide the discovery scientists in implementing these models in an optimal fashion.Keywords
This publication has 51 references indexed in Scilit:
- A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assayInternational Journal of Pharmaceutics, 2005
- Cell culture-based models for intestinal permeability: A critiqueDrug Discovery Today, 2005
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2)Biochemical Journal, 2003
- Drug–drug interaction mediated by inhibition and induction of P-glycoproteinAdvanced Drug Delivery Reviews, 2003
- Role of P-Glycoprotein in PharmacokineticsClinical Pharmacokinetics, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption ProcessesJournal of Medicinal Chemistry, 1998
- Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver: Possible roles of P-glycoprotein in biliary excretion of vincristineJournal of Hepatology, 1992
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991